Drugs & Targets Human Vaccines Project, Vanderbilt and Illumina work to decode human immunome April 14, 2017Vol.43 No.15
Drugs & TargetsFree MD Anderson, Oncora Medical cooperate on precision radiation oncology April 07, 2017Vol.43 No.14
Drugs & TargetsFree Novartis drug combination Tafinlar + Mekinist receives EU approval for BRAF V600-positive advanced NSCLC April 07, 2017Vol.43 No.14
Drugs & TargetsFree FDA accepts for review the application of Ibrutinib for cGVHD after failure of systemic therapy April 07, 2017Vol.43 No.14
Drugs & TargetsFree Amgen seeks to expand XGEVA indications to multiple myeloma in the US, Europe April 07, 2017Vol.43 No.14
Drugs & TargetsFree ESSA Pharma receives $1.2 million grant payment from CPRIT April 07, 2017Vol.43 No.14
Drugs & Targets FDA approves AstraZeneca’s Tagrisso for EGFR mutation-positive NSCLC March 31, 2017Vol.43 No.13
Drugs & Targets FDA approves niraparib for epithelial ovarian, fallopian tube, or primary peritoneal cancer March 31, 2017Vol.43 No.13
Drugs & Targets Gamida Cell receives EMA orphan drug designation for NiCord March 31, 2017Vol.43 No.13
